---
title: "Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose... — FDA record D-0371-2022 | Is It on Recall"
description: "Lack of Assurance of Sterility"
url: https://isitonrecall.com/recall/fda-drug-d-0371-2022-norepinephrine-bitartrate-injection-usp-4-mg-4-ml-1-mg-ml-4-ml-single-dose-vials-10-vials-per-carton/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Ma... — FDA record D-0371-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 31, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0703-1153-03.
- **Reason**: Lack of Assurance of Sterility
- **Classification**: Class II
- **Recalling firm**: Teva Pharmaceuticals USA
- **Quantity**: 11,450 vials
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0371-2022

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0371-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # 100020800, exp 07/2022 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Methylprednisolone, TN Norepinephrine BItartrate - MS, OH

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Mississippi](https://isitonrecall.com/state/mississippi/)
- [Ohio](https://isitonrecall.com/state/ohio/)
- [Tennessee](https://isitonrecall.com/state/tennessee/)

## Dates in the source

- **Report date**: Jan 19, 2022
- **Recall initiation date**: Dec 31, 2021
- **Center classification date**: Jan 13, 2022
- **Termination date**: Jun 4, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0371-2022%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Teva Pharmaceuticals USA records](https://isitonrecall.com/brand/teva-pharmaceuticals-usa/)